Viewing Study NCT02991456

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-02-13 @ 6:13 AM
Study NCT ID: NCT02991456
Status: COMPLETED
Last Update Posted: 2023-07-11
First Post: 2016-12-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
Sponsor: Duke University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chemo-radiation Induced Nausea and Vomiting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None malignant glioma View
None temozolomide View
None temodar View
None radiation View
None emesis View
None nausea View
None vomiting View
None chemotherapy View
None Affronti View
None Peters View
None 00076418 View